Deloitte Names Pete Lyons National Sector Leader for Life Sciences Practice
06 Dec 2022
Executive Change
Lyons brings more than 25 years of experience to the role, including helping life sciences companies drive significant transformations across the strategy, operations, and technology spectrum
BOSTON, Dec. 6, 2022 /PRNewswire/ -- Deloitte Consulting has appointed Pete Lyons as national sector leader for the life sciences practice in the U.S. Lyons succeeds Mike DeLone, principal, Deloitte Consulting LLP, who is moving to a new position as customer and marketing portfolio leader and U.S. head of Deloitte Digital.
In his new role, Lyons will lead a multi-disciplinary team serving clients across the pharmaceutical, biotechnology, medical technology, and consumer health care segments through consulting, advisory, audit and tax services.
"Pete has the background and talent to bring together our people and capabilities across audit, advisory, consulting and tax and our world-class ecosystem to drive digital transformation of the sector and meet our clients more pressing challenges," said Asif Dhar, M.D., vice chair and U.S. life sciences and health care industry leader, Deloitte LLP. "Consumers and clinicians put their trust in life sciences companies to help navigate challenges like the pandemic, find cures for disease and improve health and wellness, and I am thrilled to have Pete lead our practice and guide our clients who are at the forefront of improving lives around the world."
Lyons will be responsible for the overall strategic direction of Deloitte's life sciences practice as well as its go-to-market strategies and resources. He also will continue to serve as the U.S life sciences consulting leader.
"Life sciences has never been more in the spotlight, and I continue to be energized by organizations who are addressing some of the world's most pressing health challenges as they navigate the convergence of people, process and technology," said Lyons. "Our job is to help them focus on what they do best — bringing therapies, treatments, devices, and cures to market — and through our talented teams, our commitment to innovation and our dedication to an equitable future I am confident we will help our clients succeed."
With 25 years of experience, Lyons' past positions include U.S. consulting client excellence leader where he was responsible for managing the full client portfolio and how to effectively bring Deloitte services to market through its client leaders. He earned a B.S. in economics and information systems from Boston College and an MBA from the Kellogg School of Management at Northwestern University.
About Deloitte
Deloitte provides industry-leading audit, consulting, tax and advisory services to many of the world's most admired brands, including nearly 90% of the Fortune 500® and more than 7,000 private companies. Our people come together for the greater good and work across the industry sectors that drive and shape today's marketplace — delivering measurable and lasting results that help reinforce public trust in our capital markets, inspire clients to see challenges as opportunities to transform and thrive, and help lead the way toward a stronger economy and a healthier society. Deloitte is proud to be part of the largest global professional services network serving our clients in the markets that are most important to them. Building on more than 175 years of service, our network of member firms spans more than 150 countries and territories. Learn how Deloitte's approximately 415,000 people worldwide connect for impact at .
Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee ("DTTL"), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as "Deloitte Global") does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the "Deloitte" name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see to learn more about our global network of member firms.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.